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Abstract
Background: Disease-related foot pathology is recognised to have a significant impact on mobility and functional
capacity in the majority of patients with rheumatoid arthritis (RA). The forefoot is widely affected and the
metatarsophalangeal (MTP) joints are the most common site of symptoms. The plantar plates are the fibrocartilaginous
distal attachments of the plantar fascia inserting into the five proximal phalanges. Together with the transverse metatarsal
ligament they prevent splaying of the forefoot and subluxation of the MTP joints. Damage to the plantar plates is a
plausible mechanism therefore, through which the forefoot presentation, commonly described as ‘walking on pebbles’,
may develop in patients with RA.
The aims of this study were to investigate the relationship between plantar plate pathology and clinical, biomechanical
and plain radiography findings in the painful forefoot of patients with RA. Secondly, to compare plantar plate pathology
at the symptomatic lesser (2nd-5th) MTP joints in patients with RA, with a group of healthy age and gender matched
control subjects without foot pain.
Methods: In 41 patients with RA and ten control subjects the forefoot was imaged using 3T MRI. Intermediate
weighted fat-suppressed sagittal and short axis sequences were acquired through the lesser MTP joints. Images
were read prospectively by two radiologists and consensus reached. Plantar plate pathology in patients with RA
was compared with control subjects. Multivariable multilevel modelling was used to assess the association between
plantar plate pathology and the clinical, biomechanical and plain radiography findings.
Results: There were significant differences between control subjects and patients with RA in the presence of plantar
plate pathology at the lesser MTP joints. No substantive or statistically significant associations were found between
plantar plate pathology and clinical and biomechanical findings. The presence of plantar plate pathology was
independently associated with an increase in the odds of erosion (OR = 52.50 [8.38–326.97], p < 0.001).
Conclusion: The distribution of plantar plate pathology at the lesser MTP joints in healthy control subjects
differs to that seen in patients with RA who have the consequence of inflammatory disease in the forefoot.
Longitudinal follow-up is required to determine the mechanism and presentation of plantar plate pathology
in the painful forefoot of patients with RA.
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Background
Forefoot pain and deformity is a common feature of
rheumatoid arthritis (RA) [1]. Despite improvements in
systemic disease management and local treatments the
mechanism of metatarsophalangeal (MTP) joint disease
is not fully understood [2–5].
Cadaveric studies of the forefoot in patients with RA
have suggested that the characteristic forefoot defor-
mities may result from a failure of the multi-segmental
ligamentous system of the MTP joints and the dynamic
effect of displacement of the plantar plates [6]. The plan-
tar plates are the fibrocartilaginous distal attachments of
the deeper layer of the plantar fascia, inserting into the
five proximal phalanges. Together with the transverse
metatarsal ligament they prevent splaying of the forefoot
and subluxation of the MTP joints.
Inflammation of the synovium in RA can cause disten-
sion and stretching of the joint capsule which sub-
sequently leads to instability. Together with repeated
hyperextension of the MTP joint during gait, it is
hypothesised that in patients with RA this may predis-
pose the plantar plates to attenuation or rupture [7]. As
a consequence, degeneration or loss of function of the
plantar plate (plantar plate pathology) is a potential
mechanism which may contribute to the characteristic
forefoot deformity, often described as ‘walking on peb-
bles,’ may occur in patients with RA.
Recent exploratory studies using magnetic resonance
imaging (MRI) have demonstrated that plantar plate
pathology is common at the lesser (2nd-5th) MTP joints
in patients with RA (79.2% of patients) and appears to
be associated with features of disease and deformity at
the lesser MTP joints [8, 9]. Plantar plate pathology was
reported to be more common at the 4th and 5th MTP
joints in patients with RA [8], in contrast to the predi-
lection for the 2nd MTP reported previously in people
without RA [10, 11]. This is supported by the frequency
of plantar plate pathology seen at the 5th MTP joint,
known to be the most common site of erosive change in
the forefoot [12–14].
This study investigated the hypothesis that plantar
plate pathology in RA is associated with specific fea-
tures of disease at the lesser MTP joints; radiographic
damage, deformity, higher peak plantar pressure, plan-
tar callus formation and disease duration. The primary
aim of this study was to use high resolution 3 Tesla
(3T) MRI to investigate the relationship between plan-
tar plate pathology and the clinical, biomechanical and
plain radiography findings in the painful forefoot of
patients with RA. The study also aimed to compare
MRI reported plantar plate pathology at the symptom-
atic lesser MTP joints in patients with RA, with a
group of healthy age and gender matched control sub-
jects without forefoot pain.
Methods
Recruitment of participants
Local Ethical Committee approval [Leeds (West) Research
Ethics Committee REC reference: 08/H1307/29] was
received and informed written consent was obtained
from all participants. Consecutive patients presenting
to a specialist Rheumatology foot clinic with a diag-
nosis of RA and pain on the plantar aspect of their
lesser MTP joints were invited to take part in the
study. All patients were diagnosed according to the
1987 American College of Rheumatology revised cri-
teria for RA [15], and were diagnosed prior to the
introduction of the 2010 RA classification criteria [16].
The anatomy and pattern of pathological changes at
the first MTP joint differs to that seen at the lesser
MTP joints, therefore the first MTP joint was ex-
cluded. Control subjects were eligible to take part if
they did not have RA or any other rheumatic disease,
or any current or previous foot pain. Participants were
excluded if they had a diagnosis of diabetes mellitus,
peripheral vascular disease of the lower extremities,
neurological disease with lower limb symptoms, a his-
tory of forefoot surgery or contraindications to having
a MRI scan.
Clinical, gait and x-ray measures
Demographic data, current medication and medical his-
tory were recorded for all participants.
Measurement of functional impairment and foot de-
formity were recorded for healthy control subjects and
patients with RA. Current pain across the plantar MTP
joint area was recorded using a 100 mm visual analogue
scale (VAS) score, with the anchors “no pain” and “worst
pain imaginable” [17]. All participants completed the
Foot Impact Scale (FIS), a self-completed foot health
outcome tool for RA [18]. Platto’s Structural Index was
used to quantify the degree of forefoot structural de-
formity [19]. The presence of plantar callus and clinically
reported subluxation at each lesser MTP joint was re-
corded by an experienced clinician (HJS).
Peak plantar pressure (kPa) at each lesser MTP joint
was measured using an emed-SF pressure platform
(Novel GmbH, Munich Germany) [20]. Using the second
step method, the average of three barefoot measure-
ments was recorded for each patient. A patient specific
mask was applied to each lesser MTP joint to calculate
the peak plantar pressure. In patients with RA only,
current disease activity was quantified using a disease
activity score (DAS 44) which included the MTP joints
[15]. Standard dorsi-plantar radiographs were taken to
identify the radiographic damage at each lesser MTP
joint. Radiographs were read and scored by an experi-
enced consultant rheumatologist (PSH) using the Larsen
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method, a 6-point grading system (0–5) for progression
of radiographic joint damage [16].
MRI protocol
All MRI sequences were acquired using a 3T Verio scan-
ner (Siemens Healthcare, Erlangen, Germany) with an
eight channel radio frequency knee coil. In patients with
RA, the more symptomatic forefoot (determined by
current VAS scores) was imaged and for control subjects
the dominant forefoot was chosen. Participants lay in a
supine position with their knee flexed and the forefoot
was placed within the coil.
Intermediate-weighted, fat-suppressed sagittal (turbo
spin echo (TSE), field of view (FOV) =130, acquisition
time (TA) =6mins, repetition time (TR) =4500-5480 ms,
echo time (TE) =34 ms, 1.5 × 0.5 × 0.3 mm resolution)
and short axis (TSE, FOV = 130, TA = 7mins, TR = 3500-
3760 ms, TE = 31-36 ms, 1.1 × 0.5 × 0.3 mm resolution)
sequences, which had been previously optimised to de-
monstrate the plantar plate and joint [8], were acquired
through the lesser MTP joints.
All MR images were read prospectively by two expe-
rienced musculoskeletal radiologists (RJH and AJG) who
were blind to the participant group, and consensus on
scoring was reached. Plantar plate pathology was defined
as absence of (failure to visualise) the plantar plate
(Fig. 1 e and f; closed arrow), or a full width or par-
tial width tear (distal or proximal, medial, central or
lateral) (Fig. 1 c and d; central-distal tear), including
failure to visualise the medial or lateral distal inser-
tions. In addition, the presence of central high signal
intensity at the distal insertion was also recorded; a
tear, rupture or discontinuity of the plantar plate has
been described as an increase in signal or hyperin-
tense focus at the insertion [7, 11] (Fig. 1 g and h;
closed arrow).
Statistical analysis
Analyses were performed with SPSS version 19.0.0.2 and
Stata 12.1.
Control subjects were compared to patients with RA
using Student’s independent sample t-tests for nor-
mally distributed interval data, Mann-Whitney U tests
for ordinal data, and Pearson’s chi-square tests for ca-
tegorical data.
In order to identify associations between features of
disease and plantar plate pathology at the lesser MTP
joints in patients with RA, initially a bivariable analysis
was undertaken at the patient level using a Spearman’s
rank correlation. Variables at the joint level were sum-
marised as either the number of affected joints (plantar
plate pathology, plantar callus formation, MTP joint
subluxation) or the maximum score recorded (Larsen
score, peak plantar pressure). Spearman’s rho >0.3 was
chosen as the threshold for preliminary evidence of a
substantive association, irrespective of statistical signifi-
cance in this study.
High signal at the plantar plate distal insertion in pa-
tients with RA was compared with the reported presence
of a tear for sensitivity, specificity, positive predictive
value, negative predictive value and accuracy.
Associations between the measures of pathology re-
corded at each joint were investigated using multilevel
regression modelling to address the clustering of joints
(level 1) within patients (level 2). Likelihood ratio tests
were conducted to show whether there was a significant
degree of clustering of joints within patients, linear re-
gression was used to model peak pressure recorded in
each of the lesser MTP joints and the natural logarithm
of the values was used to address non-normality of the
residuals. Consequently, the regression coefficients rep-
resent percentage change in peak plantar pressure.
Binary logistic regression was used to model the odds
of the presence of i) plantar plate pathology, ii) pre-
sence of erosions (Larsen grade > 1), iii) MTP joint
subluxation and iv) plantar callus formation. Bivariable
models were supplemented on an exploratory basis
with multivariable models to investigate whether plan-
tar plate pathology was independently associated with
the presence of erosions, MTP joint subluxation or
plantar callus formation when controlling for contex-
tual demographic and clinical variables.
In all modelling p < 0.1 was considered indicative of
an association of potential interest warranting further
investigation.
Results
Clinical, biomechanical and x-ray measures
Forty five patients with RA and 13 control subjects were
approached to take part in the study; 41 patients with RA
and ten control subjects met the inclusion criteria and
took part in the study. Demographic characteristics and
pain, and measures of functional impairment and foot de-
formity by group and comparisons between the control
subjects and patients with RA are given in Table 1.
In patients with RA the median (interquartile range
[IQR]) disease duration was 6.0 (1.8–13.0) years, 31
(77.55%) patients were rheumatoid factor positive and
the mean (standard deviation) DAS44 (CRP) was 2.80
(0.72). Thirty five (85.4%) patients with RA were taking
a disease modifying anti rheumatic drug (DMARD), 16
patients (39%) were taking a biologic therapy, four pa-
tients (10%) were taking oral steroids and 20 patients
(50%) were taking non-steroidal anti-inflammatory
drugs (NSAIDs). Lesser MTP joint Larsen median
(IQR) scores in patients with RA were 1.0 (0.5–2.0), 13/
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41 (31.7%) patients and 58/164 (35.4%) joints had a
Larsen score of more than one.
Plantar plate pathology on MRI
Plantar plate pathology is described initially at a patient
level and all subsequent descriptions are described per
lesser MTP joint.
At the patient level, in the control group all the
plantar plates were present (Fig. 1 a and b; intact
plantar plate at 3rd MTP joint). In the RA group one
or more lesser plantar plates were absent in 15 (37%)
patients. All the lesser plantar plates were absent in
one patient. In the control group a tear was identified
in only two (20%) patients. Tears in one or more of
Fig. 1 Intermediate-weighted, fat-suppressed sagittal (a) and short axis (b) MR images of 3rd MTP joint demonstrating an intact capsule and
plantar plate (white arrow) in a control subject. Sagittal (c) and short axis (d) images of a central-distal plantar plate tear (white arrow) at the
5th MTP joint in a control subject. Sagittal (e) and short axis (f) images demonstrating an absent plantar plate (closed arrow) and erosion
(open arrow) at the 5th MTP joint in a patient with RA. Sagittal (g) and short axis (h) images demonstrating a tear (high signal) (closed
arrow) in the plantar plate and erosion (open arrow) of the 2nd MTP joint in a patient with RA
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the lesser plantar plates were identified in 29 (71%)
patients with RA.
At the joint level, in the control group tears were ob-
served in two (5%) lesser plantar plates, both at 5th
MTP joint (Fig. 1 c and d). In the RA group (data was
available for 163 plantar plates; MR images were not
suitable for scoring the plantar plate of the 5th MTP
joint in one patient), 32/163 (20%) plantar plates were
absent; seven were absent at 2nd MTP joints, six at 3rd
MTP joints, seven at 4th MTP joints and 12 at 5th MTP
joints. Tears were observed in 44 (34%) of the 131
remaining plantar plates; seven tears were reported in the
plantar plates of the 2nd MTP joints, nine at 3rd MTP
joints, 11 at 4th MTP joints and 17 at 5th MTP joints.
The 5th MTP joint was the most common site for
plantar plate pathology in patients with RA (odds ratio
[95% confidence interval] relative to 2nd MTP joint 9.20
[2.77–30.51], p < 0.001) and there was little difference
between the 2nd, 3rd (1.16 [0.40–3.33], p = 0.788) and
4th (1.76 [0.61–5.03], p = 0.293) MTP joints.
Patient and joint level data for the presence of plantar
plates, presence of tears, location of tears (width and
length) and plantar plate pathology for control subjects
and patients with RA is summarised in Table 2.
High signal at the plantar plate insertion was observed
in all the lesser MTP joints of control subjects; tears
were only reported in two of these plantar plates. In pa-
tients with RA, high signal at the plantar plate insertion
was reported in 29 of the 2nd MTP joints, 31 of 3rd
Table 1 Comparison of date between control subjects (n = 10) and patients with RA (n = 41)
Demographic characteristics and pain Controls (n = 10) RA (n = 41) Test, statistic, significance
Age, yrs.: mean (SD), range 55.6 (8.0), 42–72 55.3 (11.5), 25–77 Student’s t-test, t = 0.07, p = 0.283
Sex: % female (n) 70.0% (7/10) 78.0% (32/41) Chi-sq., χ2 = 0.29, p = 0.591
VAS pain, mm: median (IQR), range 0.0 (0.0–0.3), 0–2 36.0 (18.0–70.0), 8–95 Mann-Whitney U, z = 4.87, p < 0.001
Functional impairment and foot deformity Controls (n = 10) RA (n = 41)
FISIF score: median (IQR) 1 (0–3) 13 (11–15) Mann-Whitney U, z = 4.82, p < 0.001
FISAP score: median (IQR) 0 (0–0) 16 (11–23) Mann-Whitney U, z = 4.89, p < 0.001
Platto forefoot index: median (IQR) 2 (1–2) 9 (5–10) Mann-Whitney U, z = 3.71, p < 0.001
Gait velocity, cm/s: mean (95% CI) 117.78 (4.67) 92.70 (4.38) Student’s t-test, t = 3.92, p = 0.001
Subluxation: % patients (n) 0.0% (0/10) 70.7% (29/41) Chi-sq., χ2 = 16.40, p < 0.001
% joints (n) 0.0 (0/40) 61.6% (101/164) ML log rega
Callus: % patients (n) 60.0% (6/10) 43.9% (18/41) Chi-sq., χ2 = 0.84, p = 0.360
% joints (n) 17.5% (7/40) 17.7% (29/164) ML log reg, z = −0.08, p = 0.939
Plantar plate pathology: % patients (n) 20.0% (2/10) 85.4% (35/41) Chi-sq., χ2 = 17.24, p < 0.001
% joints (n) 5.0% (2/40) 46.6% (76/163) ML log reg; z = 3.57, p < 0.001
Peak pressure, kPa:
Peak pressure, kPa:
max per patient median (IQR)
individual joint geometric mean
563.3 (454.6–773.8)
323.75
746.7 (555.0–1145.0)
399.41
Mann-Whitney U, z = 1.90, p = 0.058
ML lin reg; z = −1.66, p = 0.096
AP Activity and Participation, Chi-sq. Pearson’s chi-square, FIS Foot Impact Scale, IF Impairment and Footwear, lin linear, log logistic, ML multilevel, reg regression, t
Student’s independent samples t-statistic, VAS Visual Analogue Scale, z normal distribution standardised statistic
aThe multilevel model could not be run due to the fact that none of the control patients had any joints showing subluxation
Table 2 Comparison of plantar plate pathology between control
subjects (n = 10) and patients with RA (n = 41)
Pathology at the MTP joint level Controls (n = 10)
Joints (n = 40)
Patients (n = 41)
Joints (n = 163a)
PP present:
% patients with all 4 (n) 100.0 (10/10) 82.9% (34/41)
% joints (n) 100.0% (40/40) 80.4% (131/163)
Tear present:
% patients (n) 20.0% (2/10) 67.5% (27/40)
% joints (n) 100.0% (40/40) 80.4% (131/163)
Tear width:
medial % (n) 19.1% (25/131)
central % (n) 5.0% (2/40) 6.9% (9/131)
lateral % (n) 1.5% (2/131)
full width % (n) 2.3% (3/131)
medial/central % (n) 2.3% (3/131)
central/lateral % (n) 1.5% (2/131)
Tear length:
proximal % (n) 95.0% (38/40) 66.4% (8/131)
central % (n) 3.8% (5/131)
distal % (n) 5.0% (2/40) 29.8 (39/131)
Plantar plate pathology present:
% patients (n) 20.0% (2/10) 85.4% (35/41)
% joints (n) 5.0% (2/40) 46.6% (76/163)
aMRI data missing for 5th MTP joint in one patient with RA. PP plantar plate
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MTP joints, 29 of 4th MTP joints and 23 of 5th MTP
joints. High signal at the insertion was reported in 79
(60%) plantar plates without pathology, high signal at
the insertion had a sensitivity of 75% (95% CI 60, 87),
specificity of 9% (95% CI 4, 17), positive predictive value
of 29% (95% CI 21, 39), negative predictive value 42%
(95% CI 20, 66) and accuracy (percentage of exact agree-
ment) of 31% for detecting a tear.
Association of plantar plate pathology with disease
characteristics in RA
Bivariable associations at the patient level
The associations at the patient level (n = 41) are
given in Table 3. Evidence of a substantive association
(Spearman’s rho ≥0.3) was reported for plantar plate
pathology and Larsen score (0.60 [p < 0.001]) (demon-
strated on MR images in Fig. 1 e, f, g and h) and plantar
plate pathology and Platto forefoot structural index score
(0.40 [p = 0.010]). Only the association between plantar
plate pathology and the Larsen score would be statistically
significant at the 5% level if corrected for multiplicity
(threshold for significance p < 0.001).
Platto’s forefoot Structural Index incorporates deformity
at the first MTP joint, which was excluded in the assess-
ment of plantar plate pathology, and was therefore not in-
cluded as a dependent variable in the multilevel modelling.
In addition, clinician reported lesser MTP joint subluxation
was reported as an individual dependent variable.
Bivariable associations at the joint level
Initial models with no explanatory variables were
conducted to test for significant clustering; there was
evidence of statistically significant between-patient
variation in plantar plate pathology, presence of ero-
sion, joint subluxation, plantar callus formation and
peak pressure measurements.
The results of joint level bivariable multilevel model-
ling are given (see Additional file 1: Table A1).
In the unadjusted analyses, neither autoantibody status
(rheumatoid factor) nor disease duration was signifi-
cantly associated with plantar plate pathology. Longer
disease duration (OR (95% CI) 1.20 (1.08–1.34),
p = 0.001) and the presence of plantar plate pathology
(52.37 (8.46–323.97), p < 0.001) were, however, asso-
ciated with increased odds of erosion (Larsen grade > 1).
Multivariable multilevel associations at the joint level
The results of multivariable multilevel modelling are
presented in Table 4.
No substantive or statistically significant associations
were found between plantar plate pathology and disease
Table 3 Spearman’s correlation coefficients patient level variables and joint level variables
PPP
(N affected/4)
Larsen score
(Max)
Subluxation
(N affected/4)
Callus
(N affected /4)
Peak pressure
(Max)
Rh factor 0.19, p = 0.250 0.06, p = 0.697 0.15, p = 0.363 0.03, p = 0.859 0.26, p = 0.099
RA duration (months) 0.14, p = 0.389 0.42, p = 0.007 0.34, p = 0.030 0.37, p = 0.018 0.30, p = 0.058
PPP
(N affected/4)
- 0.60, p < 0.001 0.25, p = 0.117 0.21, p = 0.178 0.05, p = 0.774
Larsen score
(Max)
- - - - 0.19, p = 0.243
Subluxation
(N affected/4)
- - - - 0.34, p = 0.032
Platto FIS IF FIS AP VAS pain Gait velocity
Rh factor 0.25, p = 0.118 0.24, p = 0.134 −0.10, p = 0.534 0.27, p = 0.089 0.01, p = 0.937
RA duration (months) 0.56, p < 0.001 −0.04, p = 0.824 0.19, p = 0.245 0.21, p = 0.183 −0.10, p = 0.548
Age 0.01, p = 0.503 0.03, p = 0.862 0.07, p = 0.646 0.08, p = 0.602 −0.21, p = 0.197
Sex - 0.00, p = 0.988 0.00, p = 0.988 0.03, p = 0.829 0.02, p = 0.902
DAS44 (CRP) - 0.30, p = 0.062 0.47, p = 0.002 0.02, p = 0.908 −0.47, p = 0.002
PPP
(N affected/4)
0.40, p = 0.010 0.23, p = 0.152 0.22, p = 0.170 0.12, p = 0.439 −0.23, p = 0.157
Larsen score (Max) 0.50, p = 0.001 0.11, p = 0.508 0.18, p = 0.253 0.12, p = 0.458 −0.21, p = 0.194
Subluxation (N affected/4) - 0.50, p = 0.010 0.26, p = 0.100 0.18, p = 0.250 −0.33, p = 0.034
Callus (N affected/4) - 0.10, p = 0.533 0.02, p = 0.920 0.11, p = 0.483 0.11, p = 0.509
Peak pressure (Max) 0.34, p = 0.029 0.08, p = 0.634 −0.14, p = 0.389 0.18, p = 0.253 0.20, p = 0.220
Platto score - 0.32, p = 0.044 0.21, p = 0.182 0.31, p = 0.051 −0.22, p = 0.160
Rh rheumatoid, PPP plantar plate pathology; absolute rho ≥0.3 was considered preliminary evidence of substantive association
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characteristics. Neither positive rheumatoid factor nor
disease duration were found to be associated with the
odds of plantar plate pathology, consistent with the fin-
dings of the bivariable analyses. The presence of plantar
plate pathology was independently associated with an in-
crease in the odds of erosion (OR = 52.50 [8.38–326.97],
p < 0.001), as was longer disease duration independently
associated with an increase in the odds of erosion
(OR = 1.26 [1.09–1.46], p = 0.002).
Discussion
This study has used an optimised high resolution 3T
MRI protocol to identify plantar plate pathology in the
painful forefoot of a larger cross sectional group of pa-
tients with RA, and investigate the relationship between
plantar plate pathology and other features of disease.
This cross sectional study has confirmed the findings
from previous exploratory studies [8, 9]; namely that
plantar plate pathology is more commonly reported at
the 5th MTP joint in patients with RA and is associated
with erosive change at the lesser MTP joints. Although
the presence of plantar plate pathology was associated
with an increase in the odds of erosion, the resulting
large confidence intervals for the odds ratio should be
acknowledged and is likely to be limited by the numbers
(n = 41) even in this large cross sectional study. The
study findings indicate that there is preliminary evidence
to support an association between the consequences of
inflammatory disease resulting in joint damage i.e. erosion,
and mechanical changes in the forefoot (plantar plate
pathology), but it would not be appropriate to draw fur-
ther inferences about the strength of any association.
These findings are consistent with previously reported
high prevalence rates of pain and swelling at the MTP
joints in early disease which then stabilize, but the preva-
lence and severity of forefoot joint damage increase during
the course of the disease [14].
This is the first study to compare plantar plate patho-
logy within the symptomatic forefoot of patients with RA
with a group of healthy age and gender matched control
subjects without forefoot pain. Although the control sam-
ple size is very small, there were significant differences
between control subjects and patients with RA in the
presence of plantar plate pathology at the lesser MTP
joints. Tears in the plantar plate were only reported in two
control subjects without forefoot pain, both identified at
the 5th MTP joint in the central, distal region. Previous
research has reported tears in asymptomatic non-arthritic
forefeet [11] and although the aetiology of plantar plate
pathology is quite unclear, speculation includes the wea-
ring of high heels, long lesser metatarsals, hypermobility
and excessive loading during sporting activities [17, 18],
any of which may account for the tears seen in the control
subjects. The location of tears in the lesser plantar plates
in the control subjects (central, distal region) were consis-
tent with early histological descriptions [19] in which a
thin area is depicted in the central fibres at the insertion
and described as a weak area or a rupture zone [20].
Table 4 Results of joint-level multivariable multilevel modelling
Multivariable multilevel binary logistic regression:
Odds ratio (95% CI), sig.
Dependent variable
Plantar plate pathology Larsen >1 Subluxation present Callus present
RhF positive 1.98 (0.63 to 6.23),
p = 0.243
1.19 (0.13 to 10.56),
p = 0.879
4.99 (0.19 to 134.46),
p = 0.339
1.46 (0.28 to 7.71),
p = 0.652
Disease duration (months) 1.05 (0.99 to 1.12),
p = 0.118
1.26 (1.09 to 1.46),
p = 0.002
1.15 (0.96 to 1.38),
p = 0.119
1.08 (0.99 to 1.18),
p = 0.083
Plantar plate pathology present - 52.50 (8.38 to 326.97),
p < 0.001
1.77 (0.45 to 6.95),
p = 0.410
1.04 (0.34 to 3.11),
p = 0.951
Between-patient variance 1.01 (0.27 to 3.75) 4.16 (1.12 to 15.47) 13.61 (5.03 to 36.81) 1.93 (0.49 to 7.54)
Multivariable multilevel linear regression:
Percent change (95% CI), sig.
Dependent variable
Peak pressure (standard model) Peak pressure (extended model)
RhF positive 22.63 (−5.17 to 50.44), p = 0.111 15.16 (−12.00 to 42.31), p = 0.274
Disease duration (months) 0.29 (−1.23 to 1.81), p = 0.709 −0.50 (−2.10 to 1.11), p = 0.544
Plantar plate pathology present −17.47 (−37.67 to 2.74), p = 0.090 −23.11 (−45.08 to −1.14), p = 0.039
Larsen > 1 - 2.30 (−23.34 to 27.95), p = 0.860
Subluxation present - 49.48 (27.41 to 71.55), p < 0.001
Variance
Between-patient 0.05 (0.01 to 0.18), 12.5% of total 0.05 (0.02 to 0.17), 14.3% of total
Within-patient 0.35 (0.27 to 0.45), 87.5% of tota 0.30 (0.24 to 0.39), 85.7% of total
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A tear, rupture or discontinuity of the plantar plate
has been described as an increase in signal or hyperin-
tense focus at the insertion [7, 11]. Conversely, it has
been reported that increased signal intensity may be
seen at the distal part of all plantar plates, immediately
adjacent to the proximal phalanx insertion [21]. The
presence of high signal at the plantar plate insertion on
MRI in RA is not specific for a plantar plate tear,
indicating that high signal seen on standard MR at the
plantar plate insertion is not a useful sign [9]. Histo-
logical studies, considered to be the gold standard,
would be required to confirm or refute the association
of high signal at the plantar plate insertion on MRI with
plantar plate pathology.
In this cross sectional study, the results of the multi-
variable multilevel modelling did not reveal any asso-
ciation between longer disease duration and plantar
plate pathology. Despite improved systemic disease con-
trol, pain and deformity at the MTP joints in patients
with RA remains to be a common problem [4, 5]. Recent
evidence has recognised that residual disease can be
present in the feet of patients deemed to be in systemic
disease remission, even in early disease, putting patients
at risk of ongoing damage [22, 23]. It has been proposed
that inflammation of the synovium in RA can cause
distension and stretching of the joint capsule which sub-
sequently leads to instability, and with repeated hyper-
extension of the MTP joint during gait may predispose
the plantar plates to attenuation or rupture [7]. The
findings in this cross sectional study suggest plantar
plate pathology is not associated with disease duration,
indicating that plantar plate pathology may be associated
with the residual forefoot disease reported in patients
with early RA and in systemic disease remission. This
further highlights the need to undertake clinical exami-
nation of the foot irrespective of the patient’s state of
systemic disease remission.
In a previous MR arthrography exploratory study
(n = 15), clinician-reported lesser MTP joint sublu-
xation, peak plantar pressures and plantar callus forma-
tion were all shown to be associated with plantar plate
pathology [9]. In this larger cross sectional study how-
ever, associations between plantar plate pathology and
subluxation and plantar callus formation were not
found. Reporting of subluxation at the lesser MTP joints
was a subjective observation undertaken by a clinician
and not confirmed with imaging techniques. The pre-
sence of callus formation was also recorded for a single
moment in time and did not take into consideration re-
cent debridement or preventative treatment that the pa-
tient may have been exposed to. Confirmation of MTP
joint subluxation with imaging would be required to
confirm the negative associations, and therefore the
findings should be interpreted with caution.
An association between plantar plate pathology and
change in peak plantar pressure at the lesser MTP joints
in RA was identified. Joints with plantar plate pathology
yielded mean peak pressures 23% lower than those with-
out plantar plate pathology present (p = 0.039). Symptom
relief resulting from off-loading the painful and deformed
forefoot during gait has been identified as a characteristic
feature in patients with RA [24]. The patients in this larger
cross sectional study were all recruited because they com-
plained of forefoot pain and therefore it is reasonable to
assume that they may have altered their barefoot loading
patterns to compensate for forefoot impairments. This
may have led in turn to inadequate representation of true
peak plantar pressures, despite the measurement tech-
nique itself being objective. In addition, plantar plate
pathology has been shown to be more common at the 5th
MTP joint and associated with erosive damage; however
the 5th MTP joint is typically exposed to lower mecha-
nical loads than the 2nd MTP joint in patients with RA
[25, 26]. The predominantly lateral lesser MTP joint dis-
tribution of plantar plate pathology reported in patients
with RA is consistent with the distribution of inflam-
matory destructive disease (erosions) at the MTP joints
[12, 14], indicating that the cause is unlikely to be purely
mechanical, as proposed is the case in subjects with-
out RA [17, 18].
Conclusions
In conclusion, this is largest current cross sectional study
of plantar plate pathology in the painful forefoot of pa-
tients with RA and the first to compare the findings with
healthy control subjects. The distribution of plantar plate
pathology at the lesser MTP joints in patients with RA is
associated with the presence of erosions in the forefoot of
patients with RA and differs from that seen in healthy
control subjects. The precise causative mechanism for
plantar plate pathology in RA cannot be inferred from this
cross sectional study; further longitudinal follow-up is
required to determine the specific mechanism and presen-
tation of pathology.
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